A Danish biopharmaceutical company focused on developing and commercializing treatments for brain diseases, including depression, schizophrenia, Parkinson’s disease, and migraine. Its portfolio includes several central nervous system therapies marketed globally, alongside a pipeline of neurology and...
1 member of Congress has disclosed 1 trade in H. Lundbeck A/S (HLUYY), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2020-03-18 | Greg Gianforte | buy | $1K – $15K |